Congress Trades

Coverage gap. Senate eFD: the last 13 checks failed; last successful check Oct 23. New filings from this source are not coming in. Newest Senate eFD filing on this site: 2026-10-21.

Source status

IDXXIDEXX Laboratories, Inc.

Healthcare · Diagnostics & ResearchNasdaqStockMkt cap $41.6B
Disclosed trades
64
0 in 30d · 3 in 90d
Politicians
8
Last trade Sep 25, 2026
Buys
31
$388.5K at range midpoints
Sells
31
$513K at range midpoints

Closing price · 365 days

Nov 6, 2025 – Nov 5, 2026

Monthly buys vs sells · 24 months

Counts of disclosed transactions
  • Buys
  • Sells (incl. partial)

Politicians who traded it

5 hold it now Estimated
Politicians who traded IDXX
PoliticianSeatTradesBuysSellsBought (mid)Sold (mid)Last tradeEst. position Estimated
DRo KhannaHouse · CA-17351716$185K$226KSep 25, 2026$34.8K
DApril McClain DelaneyHouse · MD-061257$40K$56KJan 13, 2026$7K
RTommy TubervilleSenate · AL532$24K$16KJan 22, 2024$870
DGilbert Ray Cisneros, Jr.House · CA-31413$8K$24KOct 9, 2020—
RJefferson ShreveHouse · IN-06321$107.5K$175KMay 12, 2025—
RRobert P. Bresnahan, Jr.House · PA-08321$16K$8KMay 15, 2025$10.5K
RByron DonaldsHouse · FL-19220$16K$0Sep 4, 2025$16.8K
RPeter MeijerHouse · MI-03101$0$8KFeb 16, 2021—

Recent trades

Disclosed trades
PoliticianTickerAssetTypeOwnerAmountvs S&P EstimatedTradedFiledSource
DRo KhannaIDXXIDEXXLABORATORIESCMNBuySpouse$1,001 - $15,000+38.1%Sep 25, 2026Oct 7, 202612dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNSellDependent$15,001 - $50,000-38.1%Sep 11, 2026Oct 7, 202626dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIESCMNSellSpouse$1,001 - $15,000-38.1%Sep 4, 2026Oct 7, 202633dFilingOCR
DRo KhannaIDXXIDEXXLABORATORIESCMNBuySpouse$1,001 - $15,000+30.1%Aug 3, 2026Sep 4, 202632dFilingOCR
DRo KhannaIDXXIDEXXLABORATORIESCMNSellSpouse$1,001 - $15,000-21.1%Jun 30, 2026Jul 6, 20266dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuySpouse$1,001 - $15,000+16.4%May 27, 2026Jun 9, 202613dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNUnknownReviewSpouse$1,001 - $15,000—May 15, 2026Jun 9, 202625dFilingOCR
DRo KhannaIDXXIDEXXLABORATORIESCMNPartialSelf$1,001 - $15,000-16.4%May 1, 2026Jun 9, 202639dFilingOCR
DRo KhannaIDXXIDEXXLABORATORIESCMNBuySpouse$1,001 - $15,000+26.9%Apr 13, 2026May 11, 202628dFilingOCR
DRo KhannaIDXXIDEXXLABORATORIESCMNBuyDependent$15,001 - $50,000+5.5%Mar 30, 2026Apr 7, 20268dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuyDependent$1,001 - $15,000+1.8%Feb 24, 2026Mar 9, 202613dFilingOCR
DRo KhannaIDXXIDEXXLABORATORIESCMNSellSpouse$15,001 - $50,000+2.1%Jan 29, 2026Feb 6, 20268dFilingOCR
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)SellDependent$1,001 - $15,000+0.5%Jan 13, 2026Feb 2, 202620dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000+8.3%Dec 2, 2025Jan 5, 202634dFiling
DRo KhannaIDXXIDEXX LABORATORIES CMNUnknownReviewSelf$1,001 - $15,000—Oct 7, 2025Nov 6, 202530dFilingOCR
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000+15.7%Oct 29, 2025Nov 4, 20256dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000+15.7%Oct 16, 2025Nov 4, 202519dFiling
RByron DonaldsIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySpouse$1,001 - $15,000-2.6%Sep 4, 2025Oct 7, 202533dFiling
RByron DonaldsIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$1,001 - $15,000-2.6%Sep 4, 2025Oct 7, 202533dFiling
DRo KhannaIDXXIDEXX LABORATORIES CMNSellSpouse$1,001 - $15,000+3.3%Sep 5, 2025Oct 3, 202528dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuySpouse$1,001 - $15,000-10.4%Aug 4, 2025Sep 9, 202536dFilingOCR
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000+9.6%Aug 7, 2025Sep 2, 202526dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000+9.6%Aug 1, 2025Sep 2, 202532dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000+12.2%Jul 9, 2025Aug 5, 202527dFiling
RJefferson ShreveIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)SellSelf$100,001 - $250,000-5.7%May 12, 2025Jun 22, 202541dFiling
RRobert P. Bresnahan, Jr.IDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$1,001 - $15,000+7.1%May 15, 2025Jun 9, 202525dFiling
DRo KhannaIDXXIDEXX LABORATORIES CMNSellSpouse$1,001 - $15,000-5.9%Apr 23, 2025May 12, 202519dFilingOCR
RJefferson ShreveIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$50,001 - $100,000+7.2%Apr 7, 2025May 8, 202531dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000+12.8%Apr 9, 2025May 2, 202523dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000+12.8%Apr 7, 2025May 2, 202525dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000+12.8%Apr 4, 2025May 2, 202528dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000+12.8%Apr 1, 2025May 2, 202531dFiling
RRobert P. Bresnahan, Jr.IDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)SellSelf$1,001 - $15,000-21.5%Apr 8, 2025Apr 28, 202520dFiling
RJefferson ShreveIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$15,001 - $50,000+34.3%Mar 13, 2025Apr 11, 202529dFiling
DRo KhannaIDXXIDEXX LABORATORIES CMNPartialSpouse$1,001 - $15,000-35.9%Mar 6, 2025Apr 10, 202535dFilingOCR
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000+27.5%Mar 14, 2025Apr 2, 202519dFiling
RRobert P. Bresnahan, Jr.IDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$1,001 - $15,000+29.5%Feb 25, 2025Mar 27, 202530dFiling
DRo KhannaIDXXIDEXX LABORATORIES CMNBuySpouse$1,001 - $15,000+28.3%Feb 19, 2025Mar 6, 202515dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuyDependent$1,001 - $15,000+30.8%Dec 18, 2024Jan 8, 202521dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuySpouse$1,001 - $15,000+30.8%Dec 16, 2024Jan 8, 202523dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNSellDependent$1,001 - $15,000-36.1%Nov 15, 2024Dec 5, 202420dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNSellSpouse$1,001 - $15,000-36.1%Nov 12, 2024Dec 5, 202423dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuyReviewUnknown$1,001 - $15,000+6.3%Aug 5, 2024Sep 6, 202432dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNPartialDependent$1,001 - $15,000-2.3%Jul 2, 2024Aug 7, 202436dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNPartialDependent$1,001 - $15,000+12.3%Mar 25, 2024Apr 5, 202411dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuyDependent$1,001 - $15,000-23.5%Feb 13, 2024Mar 6, 202422dFilingOCR
RTommy TubervilleIDXXIDEXX Laboratories, Inc. - Common StockSellJoint$1,001 - $15,000+27.4%Jan 22, 2024Feb 14, 202423dFiling
DRo KhannaIDXXIDEXX LABORATORIES CMNBuyDependent$1,001 - $15,000-32.6%Nov 3, 2023Dec 6, 202333dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNBuySpouse$15,001 - $50,000-10.8%Oct 31, 2023Nov 8, 20238dFilingOCR
DRo KhannaIDXXIDEXX LABORATORIES CMNSellDependent$15,001 - $50,000+10.8%Oct 26, 2023Nov 8, 202313dFilingOCR

Insider activity Filed

Insiders
24
In Vitro & In Vivo Diagnostic Substances
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
22
$28.6M sold
Net · 90d
-$28.6M
-$65.1M net over 12 months · last Nov 4, 2026
Insider transactions as filed on SEC Form 4
DateInsiderKindSecuritySharesPriceValuePost-holdingsD/I10b5-1Source
Nov 4, 2026filed Nov 5, 2026Sharon E. UnderbergEVP, GC & Corporate SecretaryExerciseNon-Qualified Stock Option (right-to-buy)deriv.−8,906——0D—4
Nov 4, 2026filed Nov 5, 2026Sharon E. UnderbergEVP, GC & Corporate SecretarySaleCommon Stock−1,055$690.02$727,9737,168.65D—4
Nov 4, 2026filed Nov 5, 2026Sharon E. UnderbergEVP, GC & Corporate SecretarySaleCommon Stock−1,503$689.05$1,035,6368,223.65D—4
Nov 4, 2026filed Nov 5, 2026Sharon E. UnderbergEVP, GC & Corporate SecretarySaleCommon Stock−6,348$688.25$4,368,9959,726.65D—4
Nov 4, 2026filed Nov 5, 2026Sharon E. UnderbergEVP, GC & Corporate SecretaryExerciseCommon Stock8,906$288.78$2,571,87516,074.65D—4
Nov 4, 2026filed Nov 5, 2026Jonathan Jay MazelskyExecutive Chair of the BoardExerciseNon-Qualified Stock Option (right-to-buy)deriv.−25,140——0D—4
Nov 4, 2026filed Nov 5, 2026Jonathan Jay MazelskyExecutive Chair of the BoardSaleCommon Stock−331$711.95$235,65583,803.30D—4
Nov 4, 2026filed Nov 5, 2026Jonathan Jay MazelskyExecutive Chair of the BoardSaleCommon Stock−775$711.31$551,26484,134.30D—4
Nov 4, 2026filed Nov 5, 2026Jonathan Jay MazelskyExecutive Chair of the BoardSaleCommon Stock−1,501$710.12$1,065,89184,909.30D—4
Nov 4, 2026filed Nov 5, 2026Jonathan Jay MazelskyExecutive Chair of the BoardSaleCommon Stock−1,300$709.00$921,70286,410.30D—4

Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).

Unusual activity Estimated